Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230269
Status:
COMPLETED
Last Update Posted:
2012-07-12
First Post:
2005-09-28
Brief Title:
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In patients with cancer of the head and neck and rectum knowing the exact location of the tumor is important for designing the radiation field to ensure delivery of high dose of radiation to the tumor while sparing surrounding normal tissues A new medical imaging method which is a combination of positron emission tomography PET and computed tomography CT scan has shown promise in helping the radiation oncologist in defining the exact location and extent of the tumor in certain cancers such as lung cancers Therefore the purpose of this study is to determine if these imaging methods can be used in combination with the standard radiation treatment planning procedure to improve the accuracy to targeting your tumor with radiation In addition the PET-CT scan similar to the PET scan alone with better resolution can be used to determine whether the tumor has spread to any part of the body outside of the head and neck sites
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCT00230269 | None | None | None |
| ENT0005 | None | None | None |